1. Search Result
Search Result
Results for "

Chemical Inhibitors

" in MedChemExpress (MCE) Product Catalog:

9378

Inhibitors & Agonists

16

Screening Libraries

2

Fluorescent Dye

15

Biochemical Assay Reagents

2

Peptides

1

MCE Kits

17

Natural
Products

6

Isotope-Labeled Compounds

1

Click Chemistry

9218

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-100816
    Rbin-1
    2 Publications Verification

    Ribozinoindole-1

    Phosphatase Metabolic Disease
    Rbin-1 is a potent, reversible, and specific chemical inhibitor of eukaryotic ribosome biogenesis. Rbin-1 inhibits the ATPase with GI50 of 136 nM. Rbin-1 is a potent and selective chemical inhibitor of Midasin (Mdn1).
    Rbin-1
  • HY-N1724
    Concanamycin A
    10+ Cited Publications

    Antibiotic X 4357B; Folimycin; X 4357B

    Proton Pump Bacterial Antibiotic Infection Inflammation/Immunology Cancer
    Concanamycin A (Folimycin; Antibiotic X 4357B) is a macrolide antibiotic, a vacuolar type H +-ATPase (V-ATPase) inhibitor. Concanamycin A is also an inhibitor of lysosomal acidification, can be used to T cell-mediated inflammation research - .
    Concanamycin A
  • HY-112670
    Exo1
    4 Publications Verification

    Others Others
    Exo1 is a chemical inhibitor of the exocytic pathway.
    Exo1
  • HY-52101
    CMK
    5+ Cited Publications

    Ribosomal S6 Kinase (RSK) Cancer
    CMK is a RSK2 kinase inhibitor which exhibits similar potency but less chemical stability compared with FMK.
    CMK
  • HY-B1127

    N-Benzoyl-β-alanine

    Bacterial Antibiotic Others
    Betamipron is a chemical compound which is used together with Panipenem to inhibit Panipenem uptake into the renal tubule and prevent nephrotoxicity.
    Betamipron
  • HY-112565
    MBX-4132
    1 Publications Verification

    Bacterial Infection
    MBX-4132, a member of a chemical class called oxadiazoles that inhibit trans translation by binding to the bacterial ribosome.
    MBX-4132
  • HY-W438351

    RANKL/RANK Metabolic Disease
    1,3-Dibenzyl-5-fluorouracil is a chemical inhibitor of osteoclastogenesis. 1,3-Dibenzyl-5-fluorouracil inhibits the expression of osteoclast markers by downregulating the receptor activator of NF-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) signaling pathways. 1,3-Dibenzyl-5-fluorouracil can be used in the study of metabolic bone diseases .
    1,3-Dibenzyl-5-fluorouracil
  • HY-B2119

    Tauroglycocholic acid sodium salt

    Biochemical Assay Reagents Endocrinology
    Sodium tauroglycocholate is an inhibitor of the biliary acid transporting system of the hepatocyte and also a surfactant used as a chemical permeation enhancer.
    Sodium tauroglycocholate
  • HY-N6857A

    Others Others
    (+)-Armepavine is a bioactive compound with pharmacological activity. As an alkaloid, (+)-Armepavine belongs to the tetrahydrobenzylisoquinoline class of compounds and may play a role in inhibiting certain diseases. The chemical structure and properties of (+)-Armepavine make it an important chemical classification in phytochemistry .
    (+)-Armepavine
  • HY-132595

    QPI-1002

    Small Interfering RNA (siRNA) MDM-2/p53 Cancer
    Teprasiran (QPI-1002) is a small interfering RNA that temporarily inhibits p53-mediated cell death that underlies acute kidney injury (AKI) .
    Teprasiran
  • HY-132595A

    QPI-1002 sodium

    MDM-2/p53 Cancer
    Teprasiran sodium is a small interfering RNA that temporarily inhibits p53-mediated cell death that underlies acute kidney injury (AKI) .
    Teprasiran sodium
  • HY-121649

    Topoisomerase Cancer
    AQ4 is a topoisomerase II inhibitor and DNA intercalator as a chemically stable cytotoxic agent in many human tumor lines .
    AQ4
  • HY-107635
    TMN355
    1 Publications Verification

    Cyclophilin Cardiovascular Disease
    TMN355 is a potent chemical cyclophilin A inhibitor and reduces foam cell formation and cytokine secretion. TMN355 is used for atherosclerosis .
    TMN355
  • HY-136352

    Taste Receptor Others
    Adenosine 5'-succinate is a chemically AMP-related compound and potently inhibits Denatonium benzoate/taste receptor activation of transducin .
    Adenosine 5'-succinate
  • HY-30236

    Others Cancer
    5-Bromoindole is a chemical intermediate that can be used for the synthesis of GSK-3 inhibitors and anti-cancer agents .
    5-Bromoindole
  • HY-19072

    Others Cardiovascular Disease
    BRL-36378 is an ACE inhibitor that inhibits angiotensin-converting enzyme activity. BRL-36378 can be used in ligand-based virtual screening to identify new leading structures for chemical optimization .
    BRL-36378
  • HY-112445
    SGC3027
    3 Publications Verification

    Histone Methyltransferase Cancer
    SGC3027 is a histone methyltransferase inhibitor . SGC3027 is the first potent, selective and cell active chemical probe for PRMT7 .
    SGC3027
  • HY-B1434
    7-Aminocephalosporanic acid
    1 Publications Verification

    7-ACA

    Beta-lactamase Bacterial Antibiotic Infection
    7-aminocephalosporanic acid (7-ACA) is a HSP90β inhibitor and an antibiotic. 7-Aminocephalosporanic acid is the core chemical structure of the synthesis of cephalosporin antibiotics and an effective β-lactamase inhibitor .
    7-Aminocephalosporanic acid
  • HY-RI00019

    MicroRNA Cancer
    hsa-miR-10226 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-10226 inhibitor
    hsa-miR-10226 inhibitor
  • HY-RI00057

    MicroRNA Cancer
    hsa-miR-107 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-107 inhibitor
    hsa-miR-107 inhibitor
  • HY-RI00064

    MicroRNA Cancer
    hsa-miR-11399 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-11399 inhibitor
    hsa-miR-11399 inhibitor
  • HY-RI00065

    MicroRNA Cancer
    hsa-miR-11400 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-11400 inhibitor
    hsa-miR-11400 inhibitor
  • HY-RI00066

    MicroRNA Cancer
    hsa-miR-11401 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-11401 inhibitor
    hsa-miR-11401 inhibitor
  • HY-RI00069

    MicroRNA Cancer
    hsa-miR-1179 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1179 inhibitor
    hsa-miR-1179 inhibitor
  • HY-RI00072

    MicroRNA Cancer
    hsa-miR-1182 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1182 inhibitor
    hsa-miR-1182 inhibitor
  • HY-RI00073

    MicroRNA Cancer
    hsa-miR-1183 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1183 inhibitor
    hsa-miR-1183 inhibitor
  • HY-RI00074

    MicroRNA Cancer
    hsa-miR-1184 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1184 inhibitor
    hsa-miR-1184 inhibitor
  • HY-RI00078

    MicroRNA Cancer
    hsa-miR-1193 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1193 inhibitor
    hsa-miR-1193 inhibitor
  • HY-RI00079

    MicroRNA Cancer
    hsa-miR-1197 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1197 inhibitor
    hsa-miR-1197 inhibitor
  • HY-RI00082

    MicroRNA Cancer
    hsa-miR-1202 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1202 inhibitor
    hsa-miR-1202 inhibitor
  • HY-RI00083

    MicroRNA Cancer
    hsa-miR-1203 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1203 inhibitor
    hsa-miR-1203 inhibitor
  • HY-RI00084

    MicroRNA Cancer
    hsa-miR-1204 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1204 inhibitor
    hsa-miR-1204 inhibitor
  • HY-RI00085

    MicroRNA Cancer
    hsa-miR-1205 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1205 inhibitor
    hsa-miR-1205 inhibitor
  • HY-RI00088

    MicroRNA Cancer
    hsa-miR-1208 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-1208 inhibitor
    hsa-miR-1208 inhibitor
  • HY-RI00089

    MicroRNA Cancer
    hsa-miR-12113 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12113 inhibitor
    hsa-miR-12113 inhibitor
  • HY-RI00090

    MicroRNA Cancer
    hsa-miR-12114 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12114 inhibitor
    hsa-miR-12114 inhibitor
  • HY-RI00091

    MicroRNA Cancer
    hsa-miR-12115 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12115 inhibitor
    hsa-miR-12115 inhibitor
  • HY-RI00092

    MicroRNA Cancer
    hsa-miR-12116 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12116 inhibitor
    hsa-miR-12116 inhibitor
  • HY-RI00093

    MicroRNA Cancer
    hsa-miR-12117 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12117 inhibitor
    hsa-miR-12117 inhibitor
  • HY-RI00094

    MicroRNA Cancer
    hsa-miR-12118 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12118 inhibitor
    hsa-miR-12118 inhibitor
  • HY-RI00095

    MicroRNA Cancer
    hsa-miR-12119 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12119 inhibitor
    hsa-miR-12119 inhibitor
  • HY-RI00096

    MicroRNA Cancer
    hsa-miR-12120 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12120 inhibitor
    hsa-miR-12120 inhibitor
  • HY-RI00097

    MicroRNA Cancer
    hsa-miR-12121 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12121 inhibitor
    hsa-miR-12121 inhibitor
  • HY-RI00098

    MicroRNA Cancer
    hsa-miR-12122 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12122 inhibitor
    hsa-miR-12122 inhibitor
  • HY-RI00099

    MicroRNA Cancer
    hsa-miR-12123 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12123 inhibitor
    hsa-miR-12123 inhibitor
  • HY-RI00100

    MicroRNA Cancer
    hsa-miR-12124 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12124 inhibitor
    hsa-miR-12124 inhibitor
  • HY-RI00101

    MicroRNA Cancer
    hsa-miR-12125 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12125 inhibitor
    hsa-miR-12125 inhibitor
  • HY-RI00102

    MicroRNA Cancer
    hsa-miR-12126 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12126 inhibitor
    hsa-miR-12126 inhibitor
  • HY-RI00103

    MicroRNA Cancer
    hsa-miR-12127 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12127 inhibitor
    hsa-miR-12127 inhibitor
  • HY-RI00104

    MicroRNA Cancer
    hsa-miR-12128 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-12128 inhibitor
    hsa-miR-12128 inhibitor